[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336229-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336229-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-interactions-between-metformin-and-d-limonene-inhibit-proliferation-and-promote-apoptosis-in-breast-and-liver-cancer-cells","Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells","","The study evaluates metformin and D-limonene, used singly or combined, as candidate anticancer therapeutics. Human liver and breast cancer cell lines, HepG2 and MCF-7, are analyzed using an integrated systems pharmacology drug–target–pathway network. The combination induces apoptosis in both models more effectively than single-drug treatments, supported by flow cytometry and gene expression profiling. Bax and P53 increase while Bcl-2, iNOS, and Cox-2 decrease across treatment groups. Late apoptotic cell percentages are elevated, with synergistic effects quantified by combination indices for both cell lines.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-interactions-between-metformin-and-d-limonene-inhibit-proliferation-and-promote-apoptosis-in-breast-and-liver-cancer-cells/336229/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-interactions-between-metformin-and-d-limonene-inhibit-proliferation-and-promote-apoptosis-in-breast-and-liver-cancer-cells/336229.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What anticancer agents were tested in this study?","Question",{"text":63,"@type":64},"The study assessed metformin and D-limonene, either alone or in combination, as potential anticancer therapeutics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancer cell lines were used to evaluate the treatments?",{"text":68,"@type":64},"HepG2 (human liver cancer cells) and MCF-7 (human breast cancer cells) were used as the experimental models.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular changes were observed after treatment?",{"text":72,"@type":64},"Bax and P53 mRNA levels were significantly upregulated, while Bcl-2, iNOS, and Cox-2 were significantly downregulated compared with normal cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336229,1790111707,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Salim et al.  \nBMC Complementary Medicine and Therapies (2024) 24:185  \n[https://doi.org/10.1186/s12906-024-04453-x](https://doi.org/10.1186/s12906-024-04453-x)  \nBMC Complementary Medicine and Therapies  \n RESEARCH Open Access  \nMolecular interactions between metformin   and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells  \nElsayed I. Salim 1*, Mona M. Alabasy 1, Eman M. El Nashar2, Norah S. Al‑Zahrani3, Mohammed A. Alzahrani4, Zihu Guo5, Doha M. Beltagy6 and Mohamed Shahen1*  \nAbstract  \nBackground Cancer is a fatal disease that severely affects humans. Designing new anticancer strategies and under‑ standing the mechanism of action of anticancer agents is imperative.  \nHypothesis/Purpose In this study, we evaluated the utility of metformin and D‑limonene, alone or in combination, as potential anticancer therapeutics using the human liver and breast cancer cell lines HepG2 and MCF‑7.  \nStudy design An integrated systems pharmacology approach is presented for illustrating the molecular interactions between metformin and D‑limonene.  \nMethods We applied a systems‑based analysis to introduce a drug–target–pathway network that clarifies different mechanisms of treatment. The combination treatment of metformin and D‑limonene induced apoptosis in both cell lines compared with single drug treatments, as indicated by flow cytometric and gene expression analysis.  \nResults The mRNA expression of Bax and P53 genes were significantly upregulated while Bcl-2, iNOS, and Cox-2 were significantly downregulated in all treatment groups compared with normal cells. The percentages of late apoptotic HepG2 and MCF‑7 cells were higher in all treatment groups, particularly in the combination treatment group. Cal‑ culations for the combination index (CI) revealed a synergistic effect between both drugs for HepG2 cells (CI = 0 . 14) and MCF‑7 cells (CI = 0 . 22) .  \nConclusion Our data show that metformin, D‑limonene, and their combinations exerted significant antitumor effects on the cancer cell lines by inducing apoptosis and modulating the expression of apoptotic genes.  \nKeywords Metformin, D‑limonene, HepG2, MCF‑7, Drug–target–pathway network, Gene analysis  \n*Correspondence:  \nElsayed I. Salim [elsayed.salim@science.tanta.edu.eg](elsayed.salim@science.tanta.edu.eg)[ ](elsayed.salim@science.tanta.edu.eg)Mohamed Shahen [Mshahen@science.tanta.edu.eg](Mshahen@science.tanta.edu.eg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)‑ [mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nSalim etal. BMC Complementary Medicine and Therapies (2024) 24:185  \nIntroduction  \nCancer is the leading cause of death worldwide, ","cbCaidvTWeQL7vTf","https://ap.wps.com/l/cbCaidvTWeQL7vTf","pdf",7999178,15,"English","# Abstract\n## Background\n## Hypothesis/Purpose\n## Study design\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What anticancer agents were tested in this study?\",\"answer\":\"The study assessed metformin and D-limonene, either alone or in combination, as potential anticancer therapeutics.\"},{\"question\":\"Which cancer cell lines were used to evaluate the treatments?\",\"answer\":\"HepG2 (human liver cancer cells) and MCF-7 (human breast cancer cells) were used as the experimental models.\"},{\"question\":\"What molecular changes were observed after treatment?\",\"answer\":\"Bax and P53 mRNA levels were significantly upregulated, while Bcl-2, iNOS, and Cox-2 were significantly downregulated compared with normal cells.\"}]","Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells | PDF",1790014205,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a87b35901466efbcadb4a87da3f176d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c486227337a8d619c336a63e0d913bc.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dbc4cca840076a5e53099f305e2b95f.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04a6fec96f707accfabbcb23a0368f55.webp",980,1301]